HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
C D Bucana Selected Research
C D Bucana Research Topics
Disease
20
Neoplasms (Cancer)
06/2009 - 03/2000
15
Neoplasm Metastasis (Metastasis)
06/2009 - 03/2000
10
Colonic Neoplasms (Colon Cancer)
11/2002 - 03/2000
8
Carcinoma (Carcinomatosis)
11/2002 - 03/2000
4
Melanoma (Melanoma, Malignant)
08/2003 - 03/2000
3
Ascites
11/2002 - 10/2000
3
Peritoneal Neoplasms
11/2002 - 02/2001
2
Stomach Neoplasms (Stomach Cancer)
03/2003 - 05/2002
2
Colorectal Neoplasms (Colorectal Cancer)
11/2002 - 08/2000
2
Prostatic Neoplasms (Prostate Cancer)
07/2001 - 06/2000
2
Adenocarcinoma
01/2001 - 12/2000
2
Malignant Pleural Effusion
12/2000 - 03/2000
1
Breast Neoplasms (Breast Cancer)
06/2009
1
Bone Diseases (Bone Disease)
06/2009
1
Retinal Degeneration
08/2001
1
Retinal Neovascularization
08/2001
1
Starvation
03/2001
1
Endometrial Neoplasms (Endometrial Cancer)
01/2001
1
Papillary Adenocarcinoma
01/2001
1
Lung Neoplasms (Lung Cancer)
12/2000
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2000
1
Hyperplasia
11/2000
1
Ovarian Neoplasms (Ovarian Cancer)
10/2000
1
Adenocarcinoma of Lung
03/2000
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2000
Drug/Important Bio-Agent (IBA)
14
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
08/2003 - 03/2000
7
Proteins (Proteins, Gene)
FDA Link
03/2003 - 03/2000
6
Interleukin-8 (Interleukin 8)
IBA
08/2003 - 03/2000
6
Messenger RNA (mRNA)
IBA
03/2003 - 03/2000
4
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
IBA
08/2003 - 11/2000
4
ErbB Receptors (EGF Receptor)
IBA
03/2003 - 11/2000
4
NF-kappa B (NF-kB)
IBA
07/2001 - 03/2000
3
Epidermal Growth Factor (EGF)
IBA
03/2003 - 08/2001
3
Angiopoietin-1
IBA
11/2002 - 02/2001
3
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
05/2002 - 03/2000
3
NF-KappaB Inhibitor alpha
IBA
07/2001 - 03/2000
2
Biomarkers (Surrogate Marker)
IBA
06/2009 - 10/2001
2
Paraffin
IBA
06/2009 - 03/2000
2
Interferon-beta
IBA
08/2003 - 11/2000
2
orantinib (SU6668)
IBA
10/2001 - 02/2001
2
Tyrosine Kinase Inhibitors
IBA
10/2001 - 02/2001
2
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
02/2001 - 03/2000
2
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
02/2001 - 08/2000
2
Cadherins (E-Cadherin)
IBA
06/2000 - 03/2000
2
Collagenases (Collagenase)
FDA Link
06/2000 - 03/2000
2
Matrix Metalloproteinases (MMPs)
IBA
06/2000 - 03/2000
1
Chemokine Receptors
IBA
06/2009
1
Progesterone Receptors (Progesterone Receptor)
IBA
06/2009
1
Estrogen Receptors
IBA
06/2009
1
Angiogenesis Inducing Agents (Angiogenesis Factor)
IBA
03/2003
1
Neuropilin-1
IBA
03/2003
1
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
09/2001
1
Angiopoietin-2
IBA
09/2001
1
Oxygen (Dioxygen)
IBA
08/2001
1
Cetuximab (Erbitux)
FDA Link
08/2001
1
Antibodies
IBA
08/2001
1
Transcription Factor RelA
IBA
07/2001
1
Tea
IBA
03/2001
1
Interferon-alpha (Interferon Alfa)
IBA
03/2001
1
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
03/2001
1
Growth Factor Receptors
IBA
02/2001
1
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
02/2001
1
Complementary DNA (cDNA)
IBA
02/2001
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2001
1
Cytokines
IBA
01/2001
1
Urokinase-Type Plasminogen Activator (Urokinase)
FDA Link
12/2000
1
Tissue Inhibitor of Metalloproteinase-2
IBA
12/2000
1
Transforming Growth Factor alpha (TGF-alpha)
IBA
11/2000
1
Keratins (Keratin)
IBA
09/2000
1
Silver
IBA
09/2000
1
Melanins (Melanin)
IBA
09/2000
1
Vimentin
IBA
09/2000
1
Coloring Agents (Dyes)
IBA
09/2000
1
Ethanol (Ethyl Alcohol)
IBA
09/2000
1
aloe emodin
IBA
09/2000
1
Phosphates (Orthophosphate)
IBA
08/2000
1
Prostate-Specific Antigen (Semenogelase)
IBA
06/2000
1
Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
IBA
05/2000
1
Lipopeptides
IBA
05/2000
1
Immunologic Factors (Immunomodulators)
IBA
05/2000
1
Interleukin-15 (Interleukin 15)
IBA
05/2000
1
Irinotecan (Camptosar)
FDA Link
Generic
05/2000
1
Nitric Oxide (Nitrogen Monoxide)
FDA Link
05/2000
1
JBT-3002
IBA
05/2000
1
Chemokines
IBA
03/2000
1
Chemokine CCL2 (Monocyte Chemoattractant Protein 1)
IBA
03/2000
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
03/2000
1
vatalanib (PTK787)
IBA
03/2000
1
Formaldehyde (Formol)
FDA Link
03/2000
1
Imatinib Mesylate (Gleevec)
FDA Link
03/2000
Therapy/Procedure
7
Therapeutics
06/2009 - 05/2000
3
Intraperitoneal Injections
08/2001 - 05/2000
1
Injections
03/2001
1
Intravenous Injections
12/2000
1
Prostatectomy (Retropubic Prostatectomy)
06/2000
1
Drug Therapy (Chemotherapy)
05/2000
1
Immunomodulation
05/2000